About Index Trending news
Analyze
Pricing
Abeona Therapeutics

Abeona Therapeutics

Work at Abeona Therapeutics? Add yourself to this profile

Abeona Therapeutics

Abeona is developing therapies for children with rare lysosomal diseases for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B.

Elsewhere

Contributors to this profile

Alexa global traffic share

28 Jul 2015
$8,500,000
Venture capital
George Soros
Added by

Abeona Therapeutics using CRISPR to treat Fanconi anemia, raises $8.5M

MedCity News
01 Dec 2014
$3,600,000
Venture capital
Added by

Abeona Therapeutics Raises Foundation-led $3.6M to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases

prnewswire
16 Dec 2013
$750,000
Seed fund
Added by

Biotech startup Abeona Therapeutics grabs $750K

PE Hub